Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Biobased medical mesh

Reference number
Coordinator Uppsala universitet - Uppsala universitet Inst f kemi Ångström
Funding from Vinnova SEK 500 000
Project duration November 2024 - October 2025
Status Ongoing
Venture The strategic innovation programme Bioinnovation
Call BioInnovation Hypothesis testing Step 1 - 2024

Purpose and goal

Infections and problems caused by non-degradable materials continue to be a leading cause of patient suffering and resource-intensive care, the antibacterial, bioresorbable mesh project investigates a solution that both reduces risk, promotes faster healing and reduces burden on our environment. The project combine the company Novus Scientifics´s knowledge of medical nets with Uppsala Universitets´s (UU) knowledge of gels.

Expected effects and result

1. In lab scale, validated the concept of controlled release of antibiotics from the product. 2. Acquired knowledge of the market size and market potential of the intended product. 3. A draft business model including, for example, patient groups, healthcare costs and patient benefit. The hypothesis testing must provide a basis for NO/GO for further development

Planned approach and implementation

1. Production and testing of prototype. 2. Carrying out a simplified market analysis via the Novus Scientifics contact network with a following financial analysis. 3. Prepare a sustainability analysis with an overview life cycle analysis with benchmarking against today´s medical networks.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 15 November 2024

Reference number 2024-02603